Mostrar el registro sencillo del ítem
dc.contributor.author
Li, You
dc.contributor.author
Wang, Xin
dc.contributor.author
Blau, Dianna M.
dc.contributor.author
Caballero, Mauricio Tomás
![Se ha confirmado la validez de este valor de autoridad por un usuario](/themes/CONICETDigital/images/authority_control/invisible.gif)
dc.contributor.author
Feikin, Daniel
dc.contributor.author
Gill, Christopher John
dc.contributor.author
Madhi, Shabir Ahmed
dc.contributor.author
Omer, Saad B.
dc.contributor.author
Simões, Eric A.F.
dc.contributor.author
Campbell, Harry
dc.contributor.author
Bardach, Darmaa
dc.contributor.author
Bassat, Quique
dc.contributor.author
Casalegno, Jean-Sebastien
dc.contributor.author
Crawford, Nigel W.
dc.contributor.author
Echavarria, Marcela
dc.contributor.author
Gentile, Angela
dc.contributor.author
Gordon, Aubree
dc.contributor.author
Mwananyanda, Lawrence
dc.contributor.author
Nokes, D. James
dc.contributor.author
Zar, Heather
dc.contributor.author
Nair, Harish
dc.date.available
2023-02-09T15:24:13Z
dc.date.issued
2022-01
dc.identifier.citation
Li, You; Wang, Xin; Blau, Dianna M.; Caballero, Mauricio Tomás; Feikin, Daniel; et al.; Global, Regional, and National Disease Burden Estimates of Acute Lower Respiratory Infections Due to Respiratory Syncytial Virus in Young Children in 2019: A Systematic Analysis; Elsevier; SSRN Electronic Journal; 2022; 1-2022; 1-35
dc.identifier.uri
http://hdl.handle.net/11336/187511
dc.description.abstract
Background: Respiratory syncytial virus (RSV) is the predominant cause of acute lower respiratory infection (ALRI) in young children. We previously estimated that globally in 2015, 33·1 million episodes of RSV-associated ALRI occurred in children aged 0?<60 months, resulting in a total of 118,200 community and in-hospital deaths. Since then, several community surveillance studies have been conducted to obtain a more precise estimation of RSV associated community deaths. We aimed to update RSV-associated ALRI morbidity and mortality at global, regional and national levels in children aged 0?<60 months for 2019.Methods: We expanded our global RSV disease burden dataset by obtaining new data from an updated systematic literature review (including papers published between 1st January 2017 and 31st December 2020) as well as unpublished data from 51 high-quality studies. Generalised linear mixed-effects model (GLMM) was applied to estimate RSV-associated ALRI incidence, hospital admission and in-hospital mortality both globally and regionally (by country development status and by World Bank Income Classification) in 2019. Country-level RSV-associated ALRI incidence was estimated through a risk-factor based model. We developed new models (through GLMM) that incorporated the latest RSV community mortality data for estimating overall RSV mortality (i.e., in-hospital and out-of-hospital / community).Findings: We estimated that globally in 2019, there were 33·0 million (uncertainty range, UR: 25·4?44·6) RSV-associated ALRI episodes, 3·6 million (2·9?4·6) RSV-associated ALRI hospital admissions, 26300 (15100?49100) RSV-associated ALRI in-hospital deaths, and 101400 (84500?125200) RSV-attributable overall deaths in 0?<60 months. In infants aged 0?<6 months, there were 6·6 million (4·6?9·7) RSV-associated ALRI episodes, 1·4 million (1·0?2·0) RSV-associated ALRI hospital admissions, 13300 (6800?28100) RSV-associated ALRI in-hospital deaths, and 45700 (38400?55900) RSV-attributable overall deaths. 2·0% (1·6?2·4) of overall deaths in 0?<60 months and 3·6% (3·0?4·4) of overall deaths in 28 days?<6 months were attributable to RSV. Low- and middle-income countries (LMICs) accounted for more than 95% of RSV-associated ALRI episodes and more than 97% of RSV-attributable deaths across all age bands.Interpretation: RSV represents substantial morbidity and mortality burden globally in 0?<60 months, especially during the first six months of life and in LMICs. We highlight the striking overall mortality burden of RSV disease, with one in every 50 deaths in 0?<60 months and one in every 28 deaths in 28 days?<6 months being attributable to RSV globally. RSV passive immunisation programmes targeting protection during the first six months of life could have a substantial effect on reducing RSV disease burden.
dc.format
application/pdf
dc.language.iso
eng
dc.publisher
Elsevier
dc.rights
info:eu-repo/semantics/restrictedAccess
dc.rights.uri
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
dc.subject
VIRUS SINCICIAL RESPIRATORIO
dc.subject
CARGA DE ENFERMEDAD
dc.subject
MORTALIDAD COMUNITARIA
dc.subject
MORTALIDAD
dc.subject.classification
Epidemiología
![Se ha confirmado la validez de este valor de autoridad por un usuario](/themes/CONICETDigital/images/authority_control/invisible.gif)
dc.subject.classification
Ciencias de la Salud
![Se ha confirmado la validez de este valor de autoridad por un usuario](/themes/CONICETDigital/images/authority_control/invisible.gif)
dc.subject.classification
CIENCIAS MÉDICAS Y DE LA SALUD
![Se ha confirmado la validez de este valor de autoridad por un usuario](/themes/CONICETDigital/images/authority_control/invisible.gif)
dc.title
Global, Regional, and National Disease Burden Estimates of Acute Lower Respiratory Infections Due to Respiratory Syncytial Virus in Young Children in 2019: A Systematic Analysis
dc.type
info:eu-repo/semantics/article
dc.type
info:ar-repo/semantics/artículo
dc.type
info:eu-repo/semantics/publishedVersion
dc.date.updated
2023-02-06T10:16:13Z
dc.identifier.eissn
1556-5068
dc.journal.volume
2022
dc.journal.pagination
1-35
dc.journal.pais
Estados Unidos
![Se ha confirmado la validez de este valor de autoridad por un usuario](/themes/CONICETDigital/images/authority_control/invisible.gif)
dc.description.fil
Fil: Li, You. Nanjing Medical University; China
dc.description.fil
Fil: Wang, Xin. Nanjing Medical University; China
dc.description.fil
Fil: Blau, Dianna M.. Centers for Disease Control and Prevention; Estados Unidos
dc.description.fil
Fil: Caballero, Mauricio Tomás. Fundación para la Investigación en Infectología Infantil; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina
dc.description.fil
Fil: Feikin, Daniel. Organizacion Mundial de la Salud; Argentina
dc.description.fil
Fil: Gill, Christopher John. Boston University; Estados Unidos
dc.description.fil
Fil: Madhi, Shabir Ahmed. University of the Witwatersrand; Sudáfrica
dc.description.fil
Fil: Omer, Saad B.. University of Yale; Estados Unidos
dc.description.fil
Fil: Simões, Eric A.F.. University of Colorado; Estados Unidos
dc.description.fil
Fil: Campbell, Harry. University of Edinburgh; Alemania
dc.description.fil
Fil: Bardach, Darmaa. National Health Laboratory Services; Reino Unido
dc.description.fil
Fil: Bassat, Quique. Universidad de Barcelona; España
dc.description.fil
Fil: Casalegno, Jean-Sebastien. Universidad de Lyon 3; Francia
dc.description.fil
Fil: Crawford, Nigel W.. University of Melbourne; Australia
dc.description.fil
Fil: Echavarria, Marcela. Centro de Educaciones Médicas e Investigación Clínica "Norberto Quirno"; Argentina
dc.description.fil
Fil: Gentile, Angela. Gobierno de la Ciudad de Buenos Aires. Hospital General de Niños "Ricardo Gutiérrez"; Argentina
dc.description.fil
Fil: Gordon, Aubree. University of Michigan; Estados Unidos
dc.description.fil
Fil: Mwananyanda, Lawrence. Boston University; Estados Unidos
dc.description.fil
Fil: Nokes, D. James. University of Warwick; Reino Unido
dc.description.fil
Fil: Zar, Heather. University of Cape Town; Sudáfrica
dc.description.fil
Fil: Nair, Harish. University of Edinburgh; Alemania
dc.journal.title
SSRN Electronic Journal
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/url/https://www.ssrn.com/abstract=4011896
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/doi/http://dx.doi.org/10.2139/ssrn.4011896
Archivos asociados